Infoway Releases a PrescribeIT Request for Expression of Interest to Health IT industry

(Toronto) - A Request for Expression Of Interest (REOI) was issued by Canada Health Infoway (Infoway) today, inviting private sector organizations and the health care industry to demonstrate their interest in assisting in the creation and/or the operation of PrescribeIT, Canada’s new e-prescribing service.

The REOI provides timelines and lays out opportunities for the industry to get involved and encourages advanced planning for innovative and collaborative submissions to future RFPs. Responses will help refine and improve subsequent Requests for Proposals, which will be made available on MERX.

“Canada Health Infoway is working with the provinces and territories to develop an e-prescribing service that will provide for the secure electronic transmission of a prescription from a prescriber to a patient’s pharmacy of choice,” said Michael Green, President and CEO of Infoway. “We encourage the health care industry and private sector partners to respond with creative and innovative proposals as we move towards enhanced patient safety and better health outcomes for Canadians.”

For more information about PrescribeIT and details on the Request for Expression of Interest, visit www.infoway-inforoute.ca/PrescribeIT.

About Canada Health Infoway
Infoway helps to improve the health of Canadians by working with partners to accelerate the development, adoption and effective use of digital health across Canada. Through our investments, we help deliver better quality and access to care and more efficient delivery of health services for patients and clinicians. Infoway is an independent, not-for-profit organization funded by the federal government.

-30-

For more information:

Media

Haley Armstrong
Director, Communications and Public Relations
Canada Health Infoway
519-939-9549
Email Us

For all other inquiries about PrescribeIT

Catherine Searles-Burke
Senior Manager, Marketing, PrescribeIT®
Canada Health Infoway
416.833.5152
This email address is being protected from spambots. You need JavaScript enabled to view it.
Follow @PrescribeIT_CA